At the SPAC of Dawn

Good morning! Watch this space moving forward as a roundup of evening filings as well as news nuggets to nibble on beside your morning coffee.

After a weekend in which the US markets maintained a slightly positive outlook year-to-date and hopes increased for US political stability, a war broke out from an unexpected angle.

Thus has been the story of the SPAC market in recent years through a pandemic, war, and even a hint of murder hornets. Many SPACs that have reached for the cosmos have fallen back to Earth during this time, but perhaps the story of those who made it all the way is worth telling.

Vector‘s target Rocket Lab (NASDAQ:RKLB) has been in many ways the most diverse and developed of the group, but it has had its share of struggles including a launch failure in September. Nonetheless, it opened a new 144,000-square-foot factory in California last week and will put its 172nd satellite into orbit in its next blast off.

A similar sign of optimism might be found in the terms of the newest SPAC to come to market, Colombier II. More on that to come, but suffice to say that filing a SPAC IPO with a 1/3 warrant and two years on its clock shows at least someone sees the future en rose.

Non-Redemption Agreements

• 10X Capital III (NYSE:VCXB) has agreed to send 210,000 promote shares (2.4%) and up to 630,000 (7.2%) in total to shareholders agreeing not to redeem their shares at the SPAC’s upcoming extension vote. It has a pending deal with biotech firm Addimmune.

News and Rumors

• Space de-SPACS have fallen far short of their revenue projections with only Planet and Rocket Lab keeping it tight in 2022, but trouble looms for 2023.
• Shift Technologies, which combined with Insurance Acquisition Corp. in 2020, will file for bankruptcy, will sell off inventory and is planning to shutter.
• Nigeria considers SPAC listings on its home exchange with rule proposals now appearing.